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Abstract
Purpose of the review: Among hospitalized patients, acute kidney injury is common and associated with
significant morbidity and risk for mortality. The use of electronic health records (EHR) for prediction and detection
of this important clinical syndrome has grown in the past decade. The steering committee of the 15th Acute
Dialysis Quality Initiative (ADQI) conference dedicated a workgroup with the task of identifying elements that may
impact the course of events following Acute Kidney Injury (AKI) e-alert.
Sources of information: Following an extensive, non-systematic literature search, we used a modified Delphi
process to reach consensus regarding several aspects of the utilization of AKI e-alerts.
Findings: Topics discussed in this workgroup included progress in evidence base practices, the characteristics of an
optimal e-alert, the measures of efficacy and effectiveness, and finally what responses would be considered best
practices following AKI e-alerts. Authors concluded that the current evidence for e-alert system efficacy, although
growing, remains insufficient. Technology and human-related factors were found to be crucial elements of any
future investigation or implementation of such tools. The group also concluded that implementation of such
systems should not be done without a vigorous plan to evaluate the efficacy and effectiveness of e-alerts. Efficacy
and effectiveness of e-alerts should be measured by context-specific process and patient outcomes. Finally, the
group made several suggestions regarding the clinical decision support that should be considered following
successful e-alert implementation.
Limitations: This paper reflects the findings of a non-systematic review and expert opinion.
Implications: We recommend implementation of the findings of this workgroup report for use of AKI e-alerts.
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Contexte et objectifs de la revue: L’insuffisance rénale aigüe (IRA) est un problème de santé fréquent chez les
patients hospitalisés, et elle présente un risque élevé de morbidité et de mortalité pour les personnes affectées.
L’utilisation des dossiers médicaux électroniques (DMÉ) pour la prédiction et le dépistage de ce syndrome clinique
est en croissance depuis une dizaine d’années. Le comité directeur de la 15e réunion annuelle de la Acute DIalysis
Quality Initiative (ADQI) a désigné un groupe de travail à qui il a donné le mandat d’identifier les éléments
susceptibles d’avoir une incidence sur le cours des événements à la suite d’une alerte électronique indiquant un
changement dans le taux de créatinine sérique d’un patient (alerte électronique d’IRA).
Sources et méthodologie: À la suite d’une revue exhaustive, mais non systématique de la littérature, nous avons
utilisé une version modifiée de la méthode Delphi afin de parvenir à un consensus sur plusieurs facteurs liés à
l’utilisation des alertes électroniques IRA.
Résultats/constatations: Parmi les thèmes discutés par ce groupe de travail figuraient les progrès observés au
niveau de la pratique factuelle, l’identification des caractéristiques d’une alerte électronique optimale, la façon de
mesurer l’efficacité des alertes et enfin, les interventions qualifiées de pratiques exemplaires à appliquer à la suite
d’une alerte électronique d’IRA. Les auteurs ont conclu que les connaissances actuelles sur l’efficacité des systèmes
d’alertes électroniques, bien qu’en progression, demeurent insuffisantes. Ils ont de plus identifié les facteurs
humains et technologiques comme étant des éléments clés à considérer lors d’investigations futures portant sur de
tels systèmes ou lors de leur mise en œuvre dans le futur. Le groupe de travail a également conclu que la mise en
place de tels systèmes d’alertes ne devrait toutefois pas se faire sans un programme rigoureux d’analyse de
l’efficacité et de l’efficience des alertes émises, et que ces mesures devraient se faire dans un cadre précis et en
tenant compte des résultats observés chez les patients. Enfin, les auteurs ont fait plusieurs suggestions de
mécanismes d’aide à la prise de décisions cliniques à prendre en considération à la suite de la mise en œuvre
réussie d’un système d’alertes électroniques.
Limites: Cet article fait état des conclusions obtenues dans le cadre d’une revue non systématique de la littérature
et à partir des opinions d’un groupe d’experts.
Conclusion: Nous recommandons la mise en application des conclusions émises dans le rapport présenté par le
groupe de travail sur l’utilisation des alertes électroniques IRA.
Background
Acute kidney injury (AKI) is defined by the Kidney Dis-
ease: Improving Global Outcomes (KDIGO) definition,
which is a modification of the RIFLE (risk, injury, failure,
loss, and end-stage kidney disease) and acute kidney injury
network (AKIN) consensus definitions for AKI [1–3]. This
definition involves the evaluation of an absolute or relative
increase in serum creatinine (hereafter called 'creatinine')
or oliguria for six or more hours. At first sight, these cri-
teria seem simple and straightforward. However, appropri-
ate detection of AKI requires knowledge of a baseline
creatinine or reference creatinine, calculation of urine out-
put / body weight per hour, and calculation of time pe-
riods during which the change in creatinine or urine
output occurs [4]. This makes an evaluation of the
occurrence of AKI and staging of severity complex and
labor-intensive.
Information technology is increasingly used in the
healthcare setting for the integration of all available
data as an aid to clinical decision-making. The individ-
ual elements that are necessary for the definition and
staging of AKI are typically available in the integrated
electronic health record (EHR) or intensive care clinical
information system. Therefore, an electronic sniffer
or electronic-alert (e-alert) can potentially detect
AKI each time creatinine or urine output is
recorded.
The steering committee of the 15th Acute Dialysis
Quality Initiative (ADQI) conference dedicated a work-
group with the task of considering elements that may
impact the course of events following AKI e-alert. More
specifically, they were asked to address a set of 4
questions:
1. What is the evidence base regarding AKI e-alerting?
2. What are the characteristics of an optimal e-alert?
3. How should we assess the efficacy and effectiveness
of e-alerts?
4. What responses can be considered best practices?
These questions served as a basis for accompanying
consensus statements. Our group was also asked to
provide a critical evaluation of the relevant literature
to summarize the methodology, scope, implementa-
tion and evaluative strategies for EHR-based clinical
decision support.
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Review
This consensus meeting following the established ADQI
process, as previously described [5]. The broad objective
of ADQI is to provide expert-based statements and in-
terpretation of current knowledge for use by clinicians
according to professional judgment and identify evi-
dence care gaps to establish research priorities.
The 15th ADQI Consensus Conference Chairs convened
a diverse panel representing relevant disciplines (i.e., neph-
rology, critical care, pediatrics, pharmacy, epidemiology,
health services research, biostatistics, bioinformatics and
data analytics) from five countries from North America
and Europe around the theme of “Acute Kidney Injury in
the Era of Big Data” for a 2-day consensus conference in
Banff, Canada on September 6-8, 2015.
Before the conference we searched the literature for
evidence on methodologies for design, integration and
implementation of novel applications into the electronic
health records that enable "alerting" of changes in clin-
ical status and provide a modality of clinical decision
support. A formal systematic review was not conducted.
A pre-conference series of call conferences and emails
involving the work group members was used to identify
the current state of knowledge to enable the formulation
of key questions from which discussion and consensus
would be developed.
During the conference, our work group developed
consensus positions, and plenary sessions involving all
ADQI contributors were used to present, debate, and re-
fine these positions.
Following the conference, this summary report was
generated, revised, and approved by all members of the
workgroup.
What is the evidence base regarding AKI e-alerting?
Consensus statement 1
Current evidence is limited by the number of studies, their
heterogeneity (design of the sniffer, location, clinical ac-
tion, outcomes measured, etc.), and contradictory results.
An overview of studies that report on the use of e-alerts
for AKI is presented in Table 1. We identified two groups
of studies on e-alerts and AKI. The first category reported
the utilization of an e-alert without measurement of their
impact on the process of care and patient or kidney out-
comes [6–12]. In the second group, processes of care or
outcomes were measured, but e-alerting did not improve
outcomes [13–15]. Finally, in the third set of studies, re-
corded clinical outcomes or quality of care indicated im-
provement [16–26]. Despite a relatively large number of
patients studied, the actual number of centers where these
e-alerts were evaluated was limited. In addition, we found
that there was considerable heterogeneity among studies,
which makes systematic analysis difficult.
What is an optimal e-alert?
Consensus statement 2
There are several technological and human factors that
need to be considered during the implementation and
evaluation of an AKI e-alert system. These elements in-
clude but are not limited to the clinical context, location,
provider, e-alert accuracy, the hierarchy of disruptiveness
(i.e., the extent to which the alert disrupts the current
workflow), delivery methods, alarm philosophy, and out-
come expectations in clinical and administrative settings.
The turn of events that leads to the process of care modi-
fication or clinical outcomes following the firing of an
e-alert is illustrated in Fig. 1. Although the role of the EHR
in the care and management of patients with AKI is poten-
tially important, literature regarding the characteristics of
an effective AKI e-alert is scarce. Several components have
been described to change the effectiveness and acceptance
of e-alert systems for other clinical and administrative pur-
poses. The depth of knowledge that is generated by the
EHR could be divided to basic and advanced. Basic e-alerts
disregard the clinical context or have low precision; there-
fore, it is not surprising that e-alerts with basic capabilities
are not widely accepted in the clinical practice [27–36]. In
comparison, advanced e-alerts assist clinicians by including
information regarding the clinical context and possess
significantly higher sensitivity and specificity. Advanced
e-alerts can potentially play a significant role in easing the
heavy workload of clinicians by enhancing safety measures
and efficacy without creating a distraction.
Despite the advantages of utilizing the e-alert system
abilities, the method of delivery may impact their accept-
ance into the clinical practice. Phansalkar et al. described
these features as human factors and divided them into
several distinct elements [37, 38]. These components
include: alarm philosophy (defining the unsafe situations
that require alarming), placement (within or outside of
visual horizon), visualization (target size, luminance,
background contrast), prioritization (using appropriate
wording for different urgency levels), textual information
(to include priority, information regarding the nature of
the alert, recommendation and a statement to indicate
the consequence of ignoring the alert), and habituation
(decreased response to alarms over time). Implementa-
tion of irrelevant alarms also has an adverse impact on
the acceptance of e-alerts by clinicians. These type of
alarms could be defined as warnings that do not require a
response by care providers. They are irrelevant to the pa-
tient quality of care and safety, or they generate significant
false positive warnings. Further, Seidling et al. included
these factors in a scale and based on their performance
and characteristics divided them to poor, moderate and
excellent e-alerts [39]. In order to set up a successful e-
alert system, one needs to consider other variables includ-
ing the patient setting (intensive care units (ICU) where
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patients already undergo close monitoring, versus hos-
pital ward or outpatient clinic in which patient data are
scarce), the hierarchy of disruption (the spectrum of
disruption ranging from no-alert to a hard stop without
rights to override), frequency of alerts (alert submission
till resolution of the issue versus alert submission only
once), timing (real time versus set time for submission
all in clusters), provider acknowledgement require-
ments (no need for response versus punitive measures
if response is not provided), target of e-alert (physician,
midlevel provider, trainees, nurses, or patients), and fi-
nally content of alarm (AKI diagnosis or risk prediction,
and clinical decision support). Furthermore, cultural
differences based on the type (community versus teach-
ing) and size (small versus large hospitals) of the insti-
tution, geographical locations (continents, countries,
counties), services (medical versus surgical), providers
(subspecialists, specialists, midlevel, trainee, allied
health staff ) could significantly impact the performance
of e-alerts in improvement of patient care and safety.
Finally, what is expected from the e-alert system may
define its success or failure. For example, if the expect-
ation is to improve mortality of hospitalized patients,
the alerts need to be very precise, disruptive, be tagged
with a very sophisticated clinical decision support sys-
tem, and if any study aims to show its efficacy it needs
to include a very large number of patients. In compari-
son, when e-alerts are used for administrative purposes
the level of disruptiveness and their required precision
could be completely different.
To provide an example of how differences in the
aforementioned factors can affect the performance of
AKI e-alerts in various platforms, we present two re-
cent published studies that focused on the impact of
Table 1 Use of electronic alerts for detection of acute kidney injury in clinical studies
Study Number of participants Setting Process of care Outcome
Studies reporting on the use of e-alerts without measurement of process of care or outcome
Colpaert (2007) [6] ICU
Thomas (2011) [7] 463 patients 2 hospitals
Selby (2012) [8] 2619 patients 1 hospital
Porter (2014) [9] 15,550 patients/22,754
admissions
2 hospitals
Handler (2014) [10] 249 patients 4 nursing homes
Wallace (2014) [11] 23,809 Hospital
Ahmed (2015) [12] 944 ICU
Studies reporting on the use of e-alerts: no improvement reported
Sellier (2009) [13] 603 Hospital No impact on prescription errors
Thomas (2015) [14] 308 Hospital No difference in outcome of AKI
Wilson (2015) [15] 23,664 Hospital No effect on AKI rate
Studies reporting on the use of e-alerts: improvement reported
Rind (1991) [16] 10,076 patients /13,703
admissions
Hospital Adjustment of medication
sooner
Rind (1994) [17] 20,228 admissions Hospital Adjustment of medication
sooner
Decreased risk for AKI
Chertow (2001) [18] 17,828 patients Hospital More adequate antibiotic
prescription
McCoy (2010) [19] 1237 patients Hospital More adequate medication
prescription
Terrel (2010) [20] 2783 patients visits Emergency room More adequate dosing
Cho (2012) [21] 463 patients Hospital More contrast prophylaxis Less AKI
Colpaert (2012) [22] 951 patients ICU More and earlier interventions
for AKI
Less progression AKI
Goldstein (2013) [23] 21,807 patients/27,711
admissions
Pediatric hospital Less AKI
Selby (2013) [24] 8411 patients Hospital Decreased mortality AKI
Claus (2015) [25] 87 patients ICU Decrease workload pharmacist
Kolhe (2015) [26] 2297 patients Hospital Less AKI progression Decreased
mortality
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AKI e-alerts on patient and processes of care outcomes.
Colpaert et al. described a single-center European pro-
spective interventional study in which she used AKI alert
via Digital Enhanced Cordless Technology (DECT) tele-
phone to the intensivists [22]. This alert included informa-
tion regarding changes in creatinine and urine output, and
the alert was generated whenever AKI progressed to the
next stage of RIFLE criteria [2]. She compared the pro-
cesses of care in the periods before, during, and following
alert implementation and found a significant increase in
the number and timeliness of early therapeutic interven-
tions during the alert phase. In comparison, Wilson et al.
recently published results of a randomized controlled trial
to evaluate the impact of a single alert via pager on the
outcomes of hospitalized patients in a single center in the
United States [15]. Alerts were generated solely based on
absolute or relative rise in the creatinine level in compari-
son with the lowest creatinine level measured within the
past 48 h (for 26 mmol/L [0.3 mg/dL] criteria) or 7 days
(for 50 % relative increase criteria). Authors included adult
patients from the medical and surgical ICUs, and floors
and providers who received alerts were interns, residents,
or nurse practitioners. This study did not show any im-
provement in the clinical outcomes or processes of care
among hospitalized patients. These contrasting results
highlight the importance of the e-alert system design and
human factors on the clinical performance of the system.
How do we measure alert efficacy?
Consensus statement 3
E-alert efficacy and effectiveness should be measured
proactively and encompass quality assurance, provider-
based responses, and clinical outcomes.
The use of e-alerts for a variety of conditions has ex-
panded dramatically in the past several years but has
also placed new burdens on providers [38, 40–43]. In
the best case scenarios, alerts can prevent medical error
or promote timely and appropriate treatment of a severe
condition. In the worst case scenarios, they can impede
workflow, distract providers, and lead (indirectly) to pa-
tient harm.
Therefore, e-alert systems should not be adopted with-
out a rigorous assessment of their benefit and risk across
several domains. These evaluations, where possible, should
be performed in the context of a randomized, controlled
trial. However, even in settings where the performance of
a randomized trial is not feasible, attention to key metrics
both before and after e-alert implementation will aid in
the assessment of efficacy.
Prior to the wide rollout of e-alert systems for AKI,
careful testing of the system should be performed. Pre-
testing of the system should include a systematic effort
to determine whether the e-alert is capturing all patients
of interest (by whatever AKI definition is being used)
and is not erroneously alerting for patients without AKI.
Fig. 1 The process of electronic-alert from exposure to outcome. An e-alert should impact on logistical or clinical outcomes. In this process
exposure to the e-alert components (technology and human factors, delivery methods) potentially results in a change of behavior of the provider.
Crucial to this process is the acceptance of the alert by the provider. Reproduced with permission from ADQI (www.adqi.org)
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This may be a particular issue for individuals receiving
dialysis for end-stage kidney disease, in whom inter-
dialytic creatinine fluctuation may trigger alerts. In
addition, a recent study has shown that false-positive
AKI rates may be particularly high among individuals
with chronic kidney disease when electronic monitor-
ing of creatinine levels is employed [44].
After the alert system is appropriately calibrated, devel-
opers must ensure that the proper alert target is identified
and reached. Challenges here can include identifying who
the appropriate care provider or providers are to receive an
alert and the mechanism by which they can be contacted.
Developers of e-alerts should perform system-wide im-
plementation only when the above measures have been
satisfied. Once alerting is broadly executed, several other
efficacy metrics become important.
Depending on the context of the e-alert, various provider
behaviors should be evaluated. Broadly, we consider
provider-initiated electronic documentation of AKI and or-
ders for follow-up creatinine and urine output assessment
to be important metrics of alert efficacy. Other provider
behaviors (such as the ordering of certain diagnostic tests,
studies, changing drug dosing, and avoidance of nephro-
toxins) may be appropriate efficacy measures in certain
clinical contexts.
Provider actions, such as ordering subsequent lab test-
ing, should be examined independently of the successful
completion of the order (the actual blood being drawn).
This ensures robust assessment of efficacy as well as
avoiding systematic "workarounds". For example, if a
provider is aware that an order for another creatinine
test is a quality measure, he or she may order the test
with no intention of having the test performed (for ex-
ample, by specifying the blood to be drawn at a time
after the patient is to be discharged).
Critically, clinical outcomes should be assessed in all e-
alert systems, as there is some evidence that e-alerts may
increase resource utilization without tangible patient-level
benefit [15]. In the case of AKI e-alerts, clinical outcomes
can include the receipt of dialysis, death, ICU transfer, and
change in creatinine concentration among others.
We also suggest that efforts be made to gauge provider
acceptance of e-alert systems. These studies can be
quantitative or qualitative, but they should be under-
taken concurrently with e-alert development and with
the understanding that e-alert systems that do not inte-
grate well into a provider perception of care are unlikely
to demonstrate sustained benefit.
What responses can be considered best practices?
Consensus statement 4
Following AKI alert (risk or diagnosis), the clinician
should confirm and document the risk or diagnosis in the
clinical notes and EHR. Follow-up measurement of urine
output and creatinine should be ordered, and the use of
additional diagnostics be considered. Appropriate care or
recommendations according to the best evidence-based
practices for prevention or treatment should be utilized,
and the effectiveness of clinical decision support systems
(CDS) should be evaluated.
Increased severity of AKI is associated with increas-
ing risk of death and other serious complications [45].
Therefore, there is increasing focus on the importance
of early recognition and management of AKI, with the
goal of potentially providing a wide therapeutic window
for prevention and treatment [1, 46]. The use of e-
alerts to enhance the compliance with AKI-related clin-
ical practice guidelines offer the potential for minimiz-
ing the impact of AKI [1, 22, 26, 27]. However, it is
evident that physician notification by e-alert alone is
not adequate to ensure an optimal response in patients
with probable AKI [15]. Alerts should be combined
with clear institutional clinical practice guidelines or
care bundles outlining the most appropriate response
to the level of the e-alert.
A number of clinical audits of patients with AKI have
identified deficiencies in the identification, documentation
and intervention [47, 48]. Among others, these include
failure to diagnose and document AKI, to adequately as-
sess the patient’s clinical status or to measure urine output
and sequential creatinine levels and withhold or dose-
adjust nephrotoxic medications.
Comprehensive clinical practice guidelines have been
developed by KDIGO, the UK National Clinical Guideline
Centre, and other groups, for the recognition and man-
agement of patients with AKI [1, 49]. In addition, some
healthcare centers have developed AKI care checklists to
facilitate early recognition and appropriate management
of patients with AKI [26, 50]. Tsui et al. devised an AKI
care bundle to guide the clinical response in patients with
AKI [50]. The impact of implementing an AKI care bun-
dle was studied in patients with new-onset AKI. This in-
volved a hospital-wide education campaign, although an
e-alert system was not used. Improved compliance with
appropriate investigations and initial treatments was asso-
ciated with a decreased requirement for ICU admission
and a trend towards a shorter length of stay.
Kohle et al. developed an AKI care bundle and com-
bined this with an e-alert system to notify physicians
that their patients may have developed AKI [26]. Out-
comes were compared in patients who had the care bun-
dle completed within 24 h of AKI alert versus those who
did not. Progression to higher AKI stages was lower in
patients in whom the care bundle was implemented
within 8 h. These patients also had lower odds of death
at discharge and up to 4 months post discharge.
Despite the development of guidelines for the staging and
classification of AKI and chronic kidney disease (CKD),
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kidney disease is poorly documented in physician notes,
suggesting both lack of recognition and understanding of
the importance of documentation for diagnostic coding in
administrative databases and institutional reimbursement
[51, 52]. Consequently, following receipt of an AKI e-alert
and assessment of the patient, the physician who has been
notified should document the presence of the appropriate
AKI stage in the patient’s file, problem list, and EHR. Con-
sideration should be given to the automatic exportation of
this data to the institutional administrative, and diagnostic
coding system.
The minimal clinical response to an e-alert suggesting
the presence or risk of AKI should be a full clinical and
laboratory reassessment of the patient as well as a review
of all medications by the provider receiving the e-alert.
Following the appropriate design of e-alert systems, ef-
fective utilization of change management tools and edu-
cating all stakeholders determines the success of e-alerts.
In the first step, awareness of the need to such e-alert
systems needs to be raised. Investigators and clinicians
must conduct studies to show improvement in the pro-
cesses of care or patient clinical outcomes, utilizing such
systems. In this stage, communication with all stake-
holders and asking them for their input is essential. In
the next phase, desire to participate and support using
these tools need to be instigated among all clinicians
and care providers. Providing incentives to the e-alert
targets would increase the chance of e-alert implementa-
tion success. Some of these incentives are an enhance-
ment in patient safety and quality of care, easing the
information overload and increasing hospital income by
appropriate documentation. Following raising awareness
and creating a desire to participate, stakeholders need to
be educated on the use of e-alerts and clinical decision
support systems. In this phase, some examples of best
practices could be catered to the clinicians to be used as
role models. Constant coaching and mentoring, and
removing the bottlenecks are steps need to be taken to
the next stage. And finally, e-alert utilization should be
reinforced by continuous supplement of appropriate in-
formation regarding improvement in patient outcomes
or hospital reimbursement, and even enhanced physician
reputation. Care providers then are encouraged to im-
prove their effort in the implementation of e-alert systems.
Change management tools like ADKAR (Awareness,
Desire, Knowledge, Ability, and Reinforcement) should be
considered for successful implementation of a well-
designed and targeted e-alert [53].
Conclusion
The current evidence for e-alert system efficacy and
effectiveness, although growing, remains insufficient.
Technology-related and human factors are crucial ele-
ments of any future investigation or implementation of
such tools. Implementation of such systems should not
be done without a vigorous plan to evaluate the efficacy
and effectiveness of e-alerts. Efficacy and effectiveness
of e-alerts should be measured by context-specific
process and logistical outcomes. The evidence-based
clinical decision support that should be considered fol-
lowing successful e-alert implementation include but
not limited to appropriate documentation of AKI, or-
dering context specific tests, evaluation of etiology and
providing context specific management and therapeutic
options.
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